FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

725861003: Irinotecan hydrochloride trihydrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3445886016 Irinotecan hydrochloride trihydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3445887013 Irinotecan hydrochloride trihydrate en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan hydrochloride trihydrate Is a Irinotecan hydrochloride false Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Has disposition Topoisomerase inhibitor true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Drug allergen false Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is modification of Irinotecan hydrochloride true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Substance with topoisomerase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is modification of Irinotecan false Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Piperidine true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Carbamic acid true Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate Is a Carboxylic ester true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely irinotecan hydrochloride trihydrate 40 milligram/2 milliliter conventional release solution for infusion vial Has basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 40 milligram/2 milliliter conventional release solution for infusion vial Has precise active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 100 milligram/5 milliliter conventional release solution for infusion vial Has basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 100 milligram/5 milliliter conventional release solution for infusion vial Has precise active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has basis of strength substance True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has precise active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Product containing precisely irinotecan hydrochloride trihydrate 20 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier 1
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Consilient Health Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Consilient Health Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Consilient Health Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 330mg/220ml infusion bags Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 360mg/240ml infusion bags Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 360mg/240ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 360mg/240ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 330mg/220ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 330mg/220ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 270mg/180ml infusion bags 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 360mg/240ml infusion bags 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 330mg/220ml infusion bags 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags (Sun Pharmaceutical Industries Europe B.V.) 1 bag Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 100mg/5ml solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml solution for injection vials 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 100mg/5ml solution for injection vials (Pfizer Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 40mg/2ml solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 40mg/2ml solution for injection vials (Pfizer Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml solution for injection vials 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml solution for infusion vials Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml solution for infusion vials 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml solution for infusion vials Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml solution for infusion vials 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Seacross Pharmaceuticals Ltd) Has specific active ingredient True Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier

Page 1 of 2 End


This concept is not in any reference sets

Back to Start